SASANLIMAB: 40 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
40
Total FAERS Reports
4 (10.0%)
Deaths Reported
34
Hospitalizations
40
As Primary/Secondary Suspect
4
Life-Threatening
First Report: 20190722 · Latest Report: 20231213
What Are the Most Common SASANLIMAB Side Effects?
#1 Most Reported
Neutropenic sepsis
4 reports (10.0%)
#2 Most Reported
Hypoglycaemia
3 reports (7.5%)
#3 Most Reported
Hepatitis acute
3 reports (7.5%)
All SASANLIMAB Side Effects by Frequency
No side effect data available.
Who Reports SASANLIMAB Side Effects? Age & Gender Data
Gender: 32.5% female, 67.5% male. Average age: 65.0 years. Most reports from: US. View detailed demographics →
Is SASANLIMAB Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2019 | 1 | 0 | 1 |
| 2020 | 2 | 1 | 2 |
| 2021 | 6 | 0 | 4 |
| 2022 | 27 | 2 | 25 |
| 2023 | 3 | 1 | 2 |
What Is SASANLIMAB Used For?
| Indication | Reports |
|---|---|
| Non-small cell lung cancer | 15 |
| Bladder transitional cell carcinoma | 8 |
| Bladder cancer | 7 |
Official FDA Label for SASANLIMAB
Official prescribing information from the FDA-approved drug label.